These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15110925)

  • 1. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
    Wihlbäck AC; Sundström Poromaa I; Bixo M; Allard P; Mjörndal T; Spigset O
    Psychoneuroendocrinology; 2004 Jul; 29(6):757-66. PubMed ID: 15110925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
    Wihlbäck AC; Sundström-Poromaa I; Allard P; Mjörndal T; Spigset O; Bäckström T
    Obstet Gynecol; 2001 Sep; 98(3):450-7. PubMed ID: 11530128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet serotonergic functions and light therapy in seasonal affective disorder.
    Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
    Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
    Spigset O; Mjörndal T
    Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
    Smedh K; Spigset O; Allard P; Mjörndal T; Adolfsson R
    Biol Psychiatry; 1999 Feb; 45(4):464-70. PubMed ID: 10071719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
    Spigset O; Mjörndal T
    Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults.
    Sigurdh J; Spigset O; Allard P; Mjörndal T; Hägglöf B
    Neuropsychobiology; 1999 Nov; 40(4):183-7. PubMed ID: 10559700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.
    Jurado N; Torner C; Heinze G; López G; Mendoza-Sotelo J; Lazo-Langner A; Moreno J
    Arch Med Res; 2003; 34(5):422-7. PubMed ID: 14602510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
    Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
    Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
    Melke J; Westberg L; Landén M; Sundblad C; Eriksson O; Baghei F; Rosmond R; Eriksson E; Ekman A
    Psychoneuroendocrinology; 2003 Apr; 28(3):446-58. PubMed ID: 12573307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet serotonergic binding sites in alcohol-dependent patients.
    Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
    Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Spigset O; Kristoffersson A; Mjörndal T
    Scand J Clin Lab Invest; 2004; 64(1):3-8. PubMed ID: 15025423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.